PortfoliosLab logoPortfoliosLab logo
STN.TO vs. CME
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

STN.TO vs. CME - Performance Comparison

The chart below illustrates the hypothetical performance of a CA$10,000 investment in Stantec Inc. (STN.TO) and CME Group Inc. (CME). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

STN.TO is traded in CAD, while CME is traded in USD. To make them comparable, the CME values have been converted to CAD using the latest available exchange rates.

Returns By Period

In the year-to-date period, STN.TO achieves a -20.63% return, which is significantly lower than CME's -3.78% return. Over the past 10 years, STN.TO has underperformed CME with an annualized return of 13.46%, while CME has yielded a comparatively higher 15.55% annualized return.


STN.TO

1D
-0.36%
1M
-14.21%
YTD
-20.63%
6M
-22.25%
1Y
-29.01%
3Y*
8.82%
5Y*
14.98%
10Y*
13.46%

CME

1D
-1.82%
1M
-8.53%
YTD
-3.78%
6M
-3.37%
1Y
-2.64%
3Y*
17.20%
5Y*
10.57%
10Y*
15.55%
*Multi-year figures are annualized to reflect compound growth (CAGR)

STN.TO vs. CME - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
STN.TO
Stantec Inc.
-20.63%15.61%6.81%65.43%-7.62%74.09%14.27%24.95%-13.44%5.18%
CME
CME Group Inc.
-3.78%14.36%25.18%28.20%-18.00%29.41%-8.57%5.15%43.26%23.38%

Correlation

The correlation between STN.TO and CME is 0.00, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.00

Correlation (3Y)
Calculated over the trailing 3-year period

-0.03

Correlation (5Y)
Calculated over the trailing 5-year period

0.07

Correlation (10Y)
Calculated over the trailing 10-year period

0.11

Correlation (All Time)
Calculated using the full available price history since Jul 7, 2006

0.15

The correlation between STN.TO and CME shifts across timeframes, from -0.03 (3 years) to 0.15 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

STN.TO:

CA$11.70B

CME:

$91.54B

EPS

STN.TO:

CA$4.30

CME:

$11.75

PE Ratio

STN.TO:

23.88

CME:

21.45

PEG Ratio

STN.TO:

1.00

CME:

1.87

PS Ratio

STN.TO:

1.48

CME:

13.46

PB Ratio

STN.TO:

3.47

CME:

3.44

Total Revenue (TTM)

STN.TO:

CA$7.92B

CME:

$6.76B

Gross Profit (TTM)

STN.TO:

CA$3.40B

CME:

$5.84B

EBITDA (TTM)

STN.TO:

CA$1.13B

CME:

$5.69B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

STN.TO vs. CME — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

STN.TO
STN.TO Risk / Return Rank: 66
Overall Rank
STN.TO Sharpe Ratio Rank: 44
Sharpe Ratio Rank
STN.TO Sortino Ratio Rank: 77
Sortino Ratio Rank
STN.TO Omega Ratio Rank: 77
Omega Ratio Rank
STN.TO Calmar Ratio Rank: 1212
Calmar Ratio Rank
STN.TO Martin Ratio Rank: 22
Martin Ratio Rank

CME
CME Risk / Return Rank: 3030
Overall Rank
CME Sharpe Ratio Rank: 3333
Sharpe Ratio Rank
CME Sortino Ratio Rank: 2727
Sortino Ratio Rank
CME Omega Ratio Rank: 2727
Omega Ratio Rank
CME Calmar Ratio Rank: 3535
Calmar Ratio Rank
CME Martin Ratio Rank: 2828
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

STN.TO vs. CME - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Stantec Inc. (STN.TO) and CME Group Inc. (CME). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


STN.TOCMEDifference
Sharpe ratioReturn per unit of total volatility

-0.93

Sortino ratioReturn per unit of downside risk

-1.35

Omega ratioGain probability vs. loss probability

0.82

1.00

-0.18

Calmar ratioReturn relative to maximum drawdown

-0.79

-0.13

-0.66

Martin ratioReturn relative to average drawdown

-1.77

-0.43

-1.34

STN.TO vs. CME - Sharpe Ratio Comparison

The current STN.TO Sharpe Ratio is -1.05, which is lower than the CME Sharpe Ratio of -0.13. The chart below compares the historical Sharpe Ratios of STN.TO and CME, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


STN.TOCMEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-1.05

-0.13

-0.93

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.63

0.51

+0.12

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.57

0.63

-0.06

Sharpe Ratio (All Time)

Calculated using the full available price history

0.46

0.53

-0.07

Drawdowns

STN.TO vs. CME - Drawdown Comparison

The maximum STN.TO drawdown since its inception was -58.12%, smaller than the maximum CME drawdown of -71.05%. Use the drawdown chart below to compare losses from any high point for STN.TO and CME.


Loading charts...

Drawdown Indicators


STN.TOCMEDifference

Max Drawdown

Largest peak-to-trough decline

-58.12%

-71.05%

+12.93%

Max Drawdown (1Y)

Largest decline over 1 year

-36.84%

-20.44%

-16.40%

Max Drawdown (3Y)

Largest decline over 3 years

-36.84%

-20.44%

-16.40%

Max Drawdown (5Y)

Largest decline over 5 years

-36.84%

-26.71%

-10.13%

Max Drawdown (10Y)

Largest decline over 10 years

-36.84%

-33.25%

-3.59%

Current Drawdown

Current decline from peak

-35.14%

-19.36%

-15.78%

Average Drawdown

Average peak-to-trough decline

-13.03%

-19.94%

+6.91%

Ulcer Index

Depth and duration of drawdowns from previous peaks

16.42%

6.10%

+10.32%

Volatility

STN.TO vs. CME - Volatility Comparison

Stantec Inc. (STN.TO) has a higher volatility of 13.38% compared to CME Group Inc. (CME) at 10.30%. This indicates that STN.TO's price experiences larger fluctuations and is considered to be riskier than CME based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


STN.TOCMEDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.38%

10.30%

+3.08%

Volatility (6M)

Calculated over the trailing 6-month period

23.66%

17.22%

+6.44%

Volatility (1Y)

Calculated over the trailing 1-year period

27.65%

20.91%

+6.74%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

23.76%

20.88%

+2.88%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.86%

24.73%

-0.87%

Dividends

STN.TO vs. CME - Dividend Comparison

STN.TO's dividend yield for the trailing twelve months is around 0.90%, less than CME's 4.44% yield.


PositionTTM20252024202320222021202020192018201720162015
CME
CME Group Inc.
4.44%1.83%4.48%4.58%5.05%3.00%3.24%2.74%2.42%4.20%4.90%5.41%
STN.TO
Stantec Inc.
0.90%0.69%0.74%0.73%1.11%0.93%1.50%1.58%1.84%1.42%1.33%1.22%

Financials

STN.TO vs. CME - Financials Comparison

This section allows you to compare key financial metrics between Stantec Inc. and CME Group Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


800.00M1.00B1.20B1.40B1.60B1.80B2.00B2.20B20222023202420252026
2.07B
1.88B
(STN.TO) Total Revenue
(CME) Total Revenue
Please note, different currencies. STN.TO values in CAD, CME values in USD

STN.TO vs. CME - Profitability Comparison

The chart below illustrates the profitability comparison between Stantec Inc. and CME Group Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%50.0%60.0%70.0%80.0%90.0%20222023202420252026
39.6%
88.1%
Portfolio components
STN.TO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Stantec Inc. reported a gross profit of 819.30M and revenue of 2.07B. Therefore, the gross margin over that period was 39.6%.

CME - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CME Group Inc. reported a gross profit of 1.66B and revenue of 1.88B. Therefore, the gross margin over that period was 88.1%.

STN.TO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Stantec Inc. reported an operating income of 174.60M and revenue of 2.07B, resulting in an operating margin of 8.4%.

CME - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CME Group Inc. reported an operating income of 1.31B and revenue of 1.88B, resulting in an operating margin of 69.7%.

STN.TO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Stantec Inc. reported a net income of 110.80M and revenue of 2.07B, resulting in a net margin of 5.4%.

CME - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CME Group Inc. reported a net income of 1.15B and revenue of 1.88B, resulting in a net margin of 61.4%.


Frequently Asked Questions


STN.TO and CME have a correlation of 0.00, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for STN.TO and CME

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer